Stocks On the Move: Amicus Therapeutics, Inc., Inovio Pharmaceuticals Inc, and Sky-mobi Ltd (ADR)

FOLD, INO, and MOBI are moving sharply in Monday's trading

Nov 17, 2014 at 11:27 AM
facebook twitter linkedin

Around midday, three of the top market movers are drugmakers Amicus Therapeutics, Inc. (NASDAQ:FOLD) and Inovio Pharmaceuticals Inc (NASDAQ:INO), as well as China-based app store Sky-mobi Ltd (ADR) (NASDAQ:MOBI). Here's a quick roundup of how FOLD, INO, and MOBI are performing on the charts so far.

  • FOLD has rallied 16% to trade at $6.60, following promising Phase 3 trial results for its Fabry disease treatment. Year-to-date, the shares have now tacked on more than 180%. In the options pits, however, short-term traders have been more put-focused than usual toward Amicus Therapeutics, Inc. Specifically, the stock's Schaeffer's put/call open interest ratio (SOIR) of 1.06 ranks in the 89th percentile of its annual range.

  • INO is down 8.2% to hover near $10.10, after ending its collaboration with Roche on a prostate cancer drug. The move lower has the equity now staring at a 2014 loss of roughly 13%, and at risk of closing below its 50-day moving average for the first time since Oct. 10. Should these technical struggles continue, Inovio Pharmaceuticals Inc could face a round of potential downgrades and/or price-target reductions. After all, each of the analysts covering the shares rate them a "strong buy," and INO's consensus 12-month price target of $21 is more than double the current stock price.

  • MOBI is also deep in the red today, shedding 15.3% of its value to perch at $5.92. Pressuring the shares are a poorly received third-quarter earnings report, as well as the surprise resignation of the company's chief financial officer. Nevertheless, Sky-mobi Ltd (ADR) maintains a year-to-date advance of more than 58%. Not surprisingly, short-term speculators have been focused on calls relative to puts recently. MOBI's SOIR of 0.17 indicates call open interest is more than five times put open interest, among options expiring in the next three months. Plus, this reading is lower than 88% of comparable metrics from the past year.

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!



Special Offers from Schaeffer's Trading Partners